Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM. Ten-year follow-up from the diagnosis
Authors:
- E. A. LansimiesELE. A. Lansimies
- 1 March 1996
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 45 (3) , 308-315
Abstract
Little is known about the occurrence and predictive factors of autonomic neuropathy and its relationship to cardiovascular mortality in NIDDM patients, and no long-term follow-up studies including nondiabetic control subjects are available. A total of 133 patients with newly diagnosed NIDDM (70 men) and 144 control subjects (62 men) were examined at baseline and after 5 and 10 years of follow-up. Deep-breathing tests (baseline, 5-year, and 10-year) and active orthostatic tests (5- and 10-year) were performed. Criteria for autonomic neuropathy were parasympathetic (expiration-to-inspiration ratio ≤1.10), sympathetic (systolic blood pressure decrease ≥30 mmHg in the orthostatic test), and combined autonomic neuropathy (parasympathetic with sympathetic neuropathy). The frequency of parasympathetic neuropathy (NIDDM patients versus control subjects) was 4.9 vs. 2.2% ( P = 0.224) at baseline, 19.6 vs. 8.5% ( P = 0.017) at 5 years, and 65.0 vs. 28.0% ( P < 0.001) at 10 years of follow-up. The frequency of sympathetic neuropathy was 6.8 vs. 5.6% ( P = 0.709) at 5 years and 24.4 vs. 9.0% ( P = 0.003) at 10 years of follow-up. These figures for combined autonomic neuropathy were 2.1 vs. 1.8% ( P = 0.869) at 5 years and 15.2 vs. 4.2% ( P = 0.007) at 10 years of follow-up. NIDDM patients with parasympathetic neuropathy at the 10-year examination showed worse glycemic control and higher insulin values than those without parasympathetic neuropathy. Furthermore, in our subjects, women were more prone to have parasympathetic neuropathy than men. Parasympathetic neuropathy at baseline was more frequent in those who died from a cardiovascular cause than those who did not (13 vs. 3%, P = 0.045). Similarly, sympathetic autonomic nervous dysfunction at the 5-year examination predicted the 10-year cardiovascular mortality. In conclusion, the frequency of autonomic neuropathy in NIDDM patients increases sharply with time. The development of autonomic neuropathy is connected with poor glycemic control. Interestingly, a high insulin level seems to have a predictive role in the development of parasympathetic autonomic neuropathy irrespective of obesity and glycemia.Keywords
This publication has 15 references indexed in Scilit:
- Testing of autonomic cardiovascular regulation—methodological considerationsClinical Physiology and Functional Imaging, 1989
- Nerve Glucose, Fructose, Sorbitol,myo-Inositol, and Fiber Degeneration and Regeneration in Diabetic NeuropathyNew England Journal of Medicine, 1988
- Decreased heart rate variability and its association with increased mortality after acute myocardial infarctionThe American Journal of Cardiology, 1987
- AGE-ADJUSTED NORMAL TOLERANCE LIMITS FOR CARDLOVASCULAR AUTONOMIC FUNCTION ASSESSMENT IN THE ELDERLYAge and Ageing, 1986
- The relationship of cardiovascular risk factors to the prevalence of coronary heart disease in newly diagnosed Type 2 (non-insulin-dependent) diabetesDiabetologia, 1985
- Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation.Journal of Clinical Investigation, 1983
- Reduced sinus arrhythmia in diabetic autonomic neuropathy: diagnostic value of an age-related normal range.BMJ, 1982
- Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus.Proceedings of the National Academy of Sciences, 1981
- Comparison of different analytical and precipitation methods for direct estimation of serum high-density lipoprotein cholesterolScandinavian Journal of Clinical and Laboratory Investigation, 1981
- THE NATURAL-HISTORY OF DIABETIC AUTONOMIC NEUROPATHY1980